-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Galmed Pharmaceuticals Ltd. quarterly/annual General and Administrative Expense history and growth rate from 2012 to 2023.
- Galmed Pharmaceuticals Ltd. General and Administrative Expense for the quarter ending June 30, 2024 was $688K, a 35.2% decline year-over-year.
- Galmed Pharmaceuticals Ltd. annual General and Administrative Expense for 2023 was $3.92M, a 15.7% decline from 2022.
- Galmed Pharmaceuticals Ltd. annual General and Administrative Expense for 2022 was $4.66M, a 17.8% decline from 2021.
- Galmed Pharmaceuticals Ltd. annual General and Administrative Expense for 2021 was $5.66M, a 37.1% increase from 2020.
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)